Developing drugs for the ‘undruggable’-Reference-Cited by-同舟云学术

Developing drugs for the ‘undruggable’

Published:2020-10 Issue:4 Volume:69 Page:239-241
ISSN:0736-6205
Container-title:BioTechniques
language:en
Short-container-title:BioTechniques

Author:

Sawyer Abigail¹

Affiliation:

1. Future Science Group, Unitec House, 2 Albert Pl, Finchley, London, N3 1QB, UK

Abstract

There are up to 650,000 ‘undruggable’ protein-protein interactions (PPIs) in the human interactome that can be potentially considered as novel therapeutic targets. How does the ‘undruggable’ become ‘druggable’?

Publisher

Future Science Ltd

Subject

General Biochemistry, Genetics and Molecular Biology,Biotechnology

Link

https://www.future-science.com/doi/pdf/10.2144/btn-2020-0134

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Malivhu: A Comprehensive Bioinformatics Resource for Filtering SARS and MERS Virus Proteins by Their Classification, Family and Species, and Prediction of Their Interactions Against Human Proteins;Bioinformatics and Biology Insights;2024-01

2. Antiviral PROTACs: Opportunity borne with challenge;Cell Insight;2023-06

3. PROTAC technology: A new drug design for chemical biology with many challenges in drug discovery;Drug Discovery Today;2023-01

4. Recent advancements in the discovery of cereblon-based protease-targeted chimeras with potential for therapeutic intervention;Future Medicinal Chemistry;2022-10

5. A Selective Inhibitor of Cardiac Troponin I Phosphorylation by Delta Protein Kinase C (δPKC) as a Treatment for Ischemia-Reperfusion Injury;Pharmaceuticals;2022-02-22